Overview:
Each year, major international meetings provide valuable information on practice-changing clinical information from randomized phase III trials as well as emerging novel agents. This is equally true for the hundreds of smaller trials and sub-studies that, while not garnering the national attention of many phase III trials, still provide valuable clinical information. However, many practicing oncologists are unable to attend these meetings, and may be challenged to understand and process new clinical trial information in a manner that allows for optimal application to their practices.
This virtual symposium brings together renowned experts in the diagnosis and treatment of breast cancer to provide a comprehensive overview of noteworthy data presented during the San Antonio Breast Cancer Symposium, held in San Antonio, Texas, in December 2023. This webcast is an interactive program in which faculty discuss and debate the clinical implications and applications of emerging data and the future directions of breast cancer management. Topics include current and emerging treatment options for patients with early-stage and metastatic disease as well as locoregional control using surgery and radiation. This webcast, an extension of the annual School of Breast Oncology®, provides an additional forum for clinicians to keep pace with rapidly emerging data and advancing treatment paradigms in breast cancer.
Learning objectives:
Upon completion of this activity, participants will be able to:
- Assess recently presented efficacy and safety data from clinical trials evaluating novel treatment strategies for patients with early-stage and advanced/metastatic breast cancer
- Discuss the implications of emerging evidence for clinical practice and placement in the context of evolving treatment paradigms for breast cancer
- Explain investigational strategies and novel agents designed to address clinically unmet needs in the management of breast cancer
Target Audience:
This educational activity is directed toward medical surgical and radiation oncologists, nurses, and other HCPs who treat patients with breast cancer.
Joyce O’Shaughnessy, MD
Celebrating Women Endowed Chair in Breast Cancer Research
Baylor University Medical Center Chair, Breast Cancer Prevention Research
Texas Oncology Baylor-Sammons Cancer Center
US Oncology Network
Dallas, TX
William J. Gradishar, MD, FASCO, FACP
Betsy Bramsen Professor of Breast Oncology and Professor of Medicine
Chief, Division of Hematology and Oncology
Feinberg School of Medicine
Deputy Director, Clinical Network
Director, Maggie Daley Center for Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL
Kevin Kalinsky, MD, MS
Acting Associate Professor, Department of Hematology and Medical Oncology
Director, Breast Medical Oncology
Director, Glenn Family Breast Center
Emory University School of Medicine
Winship Cancer Institute of Emory University
Director, Breast Medical Oncology
Winship Cancer Institute of Emory University
Atlanta, GA
Terry P. Mamounas, MD, MPH, FACS
Professor of Surgery
University of Central Florida College of Medicine
Clinical Professor of Clinical Sciences
Florida State University College of Medicine
Medical Director, Comprehensive Breast Program
Orlando Health Cancer Institute
Orlando, FL
School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio Location: Virtual | |
Time | |
5 min | Welcome and Introduction |
30 min | Abstract Review and Discussion: Systemic Treatment of Early-Stage Breast Cancer |
30 min | Abstract Review and Discussion: Systemic Treatment of Metastatic Breast Cancer |
30 min | Abstract Review and Discussion: Locoregional Control of Breast Cancer |
20 min | Audience Question and Answer Session |
5 min | Closing Comments and Postsession Survey |
Adjournment | |
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.